Redhawk Wealth Advisors
ABBV icon

Redhawk Wealth Advisors’s AbbVie ABBV Stock Holding History

Redhawk Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$795K Buy
3,040
+38
+1% +$9.7K 0.08% 196
2026
Q2 		$755K Sell
3,002
-159
-5% -$34.2K 0.07% 210
2026
Q1 		$688K Sell
3,161
-1
-0% -$222 0.08% 200
2025
Q4 		$722K Buy
3,162
+47
+2% +$10.7K 0.08% 194
2025
Q3 		$721K Buy
3,115
+32
+1% +$6.52K 0.08% 193
2025
Q2 		$572K Sell
3,083
-32
-1% -$5.95K 0.07% 196
2025
Q1 		$653K Buy
3,115
+570
+22% +$111K 0.09% 173
2024
Q4 		$452K Sell
2,545
-64
-2% -$11.8K 0.06% 201
2024
Q3 		$515K Buy
2,609
+78
+3% +$14.6K 0.07% 193
2024
Q2 		$434K Sell
2,531
-135
-5% -$22.4K 0.07% 201
2024
Q1 		$486K Sell
2,666
-4
-0.1% -$689 0.08% 197
2023
Q4 		$414K Buy
2,670
+6
+0.2% +$875 0.08% 195
2023
Q3 		$397K Buy
2,664
+332
+14% +$48.7K 0.13% 135
2023
Q2 		$314K Sell
2,332
-8,971
-79% -$1.32M 0.1% 151
2023
Q1 		$1.8M Buy
11,303
+376
+3% +$57.5K 0.61% 38
2022
Q4 		$1.77M Buy
10,927
+7,134
+188% +$1.09M 0.69% 30
2022
Q3 		$509K Sell
3,793
-5,357
-59% -$769K 0.22% 104
2022
Q2 		$1.4M Buy
9,150
+1,836
+25% +$281K 0.64% 32
2022
Q1 		$1.19M Buy
7,314
+3,985
+120% +$579K 0.31% 62
2021
Q4 		$451K Buy
3,329
+897
+37% +$106K 0.12% 122
2021
Q3 		$262K Buy
2,432
+378
+18% +$43.2K 0.07% 182
2021
Q2 		$231K Sell
2,054
-5,664
-73% -$638K 0.05% 217
2021
Q1 		$835K Buy
7,718
+302
+4% +$32.3K 0.21% 93
2020
Q4 		$795K Sell
7,416
-703
-9% -$67.6K 0.2% 86
2020
Q3 		$711K Buy
8,119
+2,314
+40% +$218K 0.21% 92
2020
Q2 		$570K Buy
5,805
+1,758
+43% +$155K 0.2% 82
2020
Q1 		$308K Buy
+4,047
New +$345K 0.14% 115
2019
Q3 		– Sell
-100
Closed -$7K – 137
2019
Q2 		$7K Buy
+100
New +$7.86K ﹤0.01% 401

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bahl & Gaynor
Bahl & Gaynor Cincinnati, Ohio $21B AUM 23.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Redhawk Wealth Advisors's ABBV Position: Q3 2026 in Review

Redhawk Wealth Advisors increased its AbbVie (ABBV) stake by 1.3% in Q3 2026, buying an estimated $9.7K and bringing the position to 3,040 shares worth $795K. The position accounts for 0.08% of the portfolio, ranked #196.

Redhawk Wealth Advisors first reported a position in ABBV in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.8M in Q1 2023. 2,565 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Redhawk Wealth Advisors held 3,040 shares of AbbVie worth $795K as of Q3 2026.
  • Redhawk Wealth Advisors bought 38 AbbVie shares in Q3 2026, an estimated $9.7K.
  • AbbVie made up 0.08% of Redhawk Wealth Advisors's portfolio in Q3 2026, its #196 holding.
  • Redhawk Wealth Advisors first reported a position in AbbVie in Q2 2019 and has held it in 28 quarters since.
  • Redhawk Wealth Advisors's AbbVie position peaked at $1.8M in Q1 2023.
  • 2,565 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.